Related Experiment Video
Updated: Oct 13, 2026
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Possible clinical significance of serum soluble interleukin-2 receptor level in primary bone lymphoma: two case
Hiroki Yabe1, Hironori Ueno, Kensuke Ochi
1Division of Rheumatology, Jichi Medical University Saitama Medical Center, Saitamao, Japan.
Abstract:
In two patients with primary bone lymphoma (PBL) treated in our clinic, serum levels of soluble interleukin-2 receptor (sIL-2R) reflected the clinical course. In both cases, sIL-2R levels were high before treatment and normalized with the therapeutic effects of chemotherapy, coinciding with the changes in lactate dehydrogenase levels and radiographic findings. Adding to the recently reported results of the diagnostic ability of sIL-2R in PBL, our case study highlights the clinical significance of serum sIL-2R levels as a tumor marker in PBL cases.
